These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone]. Tochigi T, Kawamura S, Numahata K, Tokuyama S, Kuwahara M, Horaguchi T, Satou S. Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702 [Abstract] [Full Text] [Related]
3. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence. Rahardjo D, Kamil ST, Pakasi LS. Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211 [Abstract] [Full Text] [Related]
4. The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men. Teoh JY, Yuen SK, Tsu JH, Wong CK, Ho BS, Ng AT, Ma WK, Ho KL, Yiu MK. Asian J Androl; 2017 May; 19(1):113-116. PubMed ID: 26620456 [Abstract] [Full Text] [Related]
5. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1. Wang C, Wang YY, Wang SY, Ding JX, Ding M, Ruan Y, Wang XH, Jing YF, Han BM, Xia SJ, Jiang CY, Zhao FJ. Asian J Androl; 2021 May; 23(4):415-420. PubMed ID: 33473011 [Abstract] [Full Text] [Related]
6. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, Ohori M, Fujii A. Cancer; 1997 May 15; 79(10):1969-76. PubMed ID: 9149025 [Abstract] [Full Text] [Related]
7. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men. Sheikh M, Al-Saeed O, Kehinde EO, Sinan T, Anim JT, Ali Y. Int Urol Nephrol; 2005 May 15; 37(4):721-6. PubMed ID: 16362587 [Abstract] [Full Text] [Related]
8. A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer. Mochtar CA, Rahardjo D, Umbas R. Gan To Kagaku Ryoho; 2000 May 15; 27 Suppl 2():514-22. PubMed ID: 10895203 [Abstract] [Full Text] [Related]
9. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer]. Martínez Jabaloyas JM, García Morata F, Villamón Fort R, Pastor Hernández F, Gil Salom M, García Sisamón F. Actas Urol Esp; 2003 Jun 15; 27(6):442-9. PubMed ID: 12918151 [Abstract] [Full Text] [Related]
10. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Bazinet M, Meshref AW, Trudel C, Aronson S, Péloquin F, Nachabe M, Bégin LR, Elhilali MM. Urology; 1994 Jan 15; 43(1):44-51; discussion 51-2. PubMed ID: 7506853 [Abstract] [Full Text] [Related]
11. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate serum prostate specific antigen levels. Tarcan T, Ozveri H, Biren T, Türkeri L, Akdas A. Int J Urol; 1997 Jul 15; 4(4):362-7. PubMed ID: 9256325 [Abstract] [Full Text] [Related]
12. [Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels]. Kihara T, Ito F, Kobayashi C, Ryoji O, Tokumoto T, Iguchi Y, Maeda Y, Onizuka S, Goya N, Nakazawa H, Toma H. Hinyokika Kiyo; 1997 Jan 15; 43(1):13-8. PubMed ID: 9046415 [Abstract] [Full Text] [Related]
13. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer. Yu HJ, Lai MK. Urology; 1998 May 15; 51(5A Suppl):125-30. PubMed ID: 9610567 [Abstract] [Full Text] [Related]
14. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? Ohori M, Dunn JK, Scardino PT. Urology; 1995 Nov 15; 46(5):666-71. PubMed ID: 7495118 [Abstract] [Full Text] [Related]
15. PSA density and prostate cancer detection. Saema A, Kochakarn W, Lertsithichai P. J Med Assoc Thai; 2012 May 15; 95(5):661-6. PubMed ID: 22994025 [Abstract] [Full Text] [Related]
16. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR, Evans WP, Borden JD, Castellanos RD. Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040 [Abstract] [Full Text] [Related]
17. The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml. Akdas A, Tarcan T, Türkeri L, Cevik I, Biren T, Ilker Y. Eur Urol; 1996 Dec 01; 29(2):189-92. PubMed ID: 8647145 [Abstract] [Full Text] [Related]
18. The use of prostate specific antigen density to predict clinically significant prostate cancer. Yusim I, Krenawi M, Mazor E, Novack V, Mabjeesh NJ. Sci Rep; 2020 Nov 17; 10(1):20015. PubMed ID: 33203873 [Abstract] [Full Text] [Related]
19. The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density. Chen Y, Jiang X, Liu R, Zhang Z, Luo F, Qi S, Xu Y. Med Sci Monit; 2019 Aug 19; 25():6230-6235. PubMed ID: 31424055 [Abstract] [Full Text] [Related]
20. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml]. Janane A, Hajji F, Ismail T, Jawad C, Elondo JC, Dakka Y, Ghadouane M, Ameur A, Abbar M, Albouzidi A. Actas Urol Esp; 2012 Feb 19; 36(2):93-8. PubMed ID: 22188752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]